NO20006506D0 - Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer - Google Patents

Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer

Info

Publication number
NO20006506D0
NO20006506D0 NO20006506A NO20006506A NO20006506D0 NO 20006506 D0 NO20006506 D0 NO 20006506D0 NO 20006506 A NO20006506 A NO 20006506A NO 20006506 A NO20006506 A NO 20006506A NO 20006506 D0 NO20006506 D0 NO 20006506D0
Authority
NO
Norway
Prior art keywords
migraine
prevention
treatment
valproic acid
acid analog
Prior art date
Application number
NO20006506A
Other languages
English (en)
Other versions
NO20006506L (no
Inventor
Heinz Nau
Emer Leahy
Alan O'connell
Original Assignee
American Biogenetic Sciences
Heinz Nau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Biogenetic Sciences, Heinz Nau filed Critical American Biogenetic Sciences
Publication of NO20006506D0 publication Critical patent/NO20006506D0/no
Publication of NO20006506L publication Critical patent/NO20006506L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20006506A 1998-06-22 2000-12-20 Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer NO20006506L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9028198P 1998-06-22 1998-06-22
PCT/US1999/014081 WO1999066920A1 (en) 1998-06-22 1999-06-22 The use of valproic acid analog for the treatment and prevention of migraine and affective illness

Publications (2)

Publication Number Publication Date
NO20006506D0 true NO20006506D0 (no) 2000-12-20
NO20006506L NO20006506L (no) 2001-02-21

Family

ID=22222101

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006506A NO20006506L (no) 1998-06-22 2000-12-20 Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer

Country Status (19)

Country Link
US (2) US6268396B1 (no)
EP (1) EP1089725A1 (no)
JP (1) JP2002518442A (no)
KR (1) KR20010071572A (no)
CN (1) CN1310622A (no)
AU (2) AU752192B2 (no)
BG (1) BG63744B1 (no)
BR (1) BR9911421A (no)
CA (1) CA2335641A1 (no)
CZ (1) CZ20004833A3 (no)
HU (1) HUP0102456A3 (no)
IL (1) IL140415A0 (no)
MX (1) MXPA00012808A (no)
NO (1) NO20006506L (no)
PL (1) PL345364A1 (no)
SK (1) SK19992000A3 (no)
TR (2) TR200003800T2 (no)
WO (1) WO1999066920A1 (no)
ZA (1) ZA200007652B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6104802A (en) 1997-02-10 2000-08-15 Genesys Telecommunications Laboratories, Inc. In-band signaling for routing
CA2372806A1 (en) * 1999-05-04 2000-11-09 Keith R. Edwards Intravenous valproate for acute treatment of migraine headache
KR100843703B1 (ko) 2000-07-21 2008-07-04 이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 양극성 장애에서의 조증을 치료하기 위한 벨프로익산 및 2-벨프로에닉산 아미드 유도체의 용도
MXPA03001458A (es) * 2000-08-17 2004-05-04 Teva Pharma Derivados de acido valproico para el tratamiento del dolor.
US20020103110A1 (en) * 2001-01-26 2002-08-01 Spitzer A. Robert System and method for rectal administration of medication for treatment of migraines
US7968569B2 (en) * 2002-05-17 2011-06-28 Celgene Corporation Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
WO2004037843A2 (en) * 2002-10-25 2004-05-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
WO2004050084A2 (en) * 2002-11-29 2004-06-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ace-inhibitors having antioxidant and nitricoxid-donor activity
CA2508855A1 (en) * 2002-12-16 2004-07-01 Frank Slade Abbott Valproic acid analogues and pharmaceutical compositions thereof
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
WO2006012603A2 (en) * 2004-07-22 2006-02-02 Nps Pharmaceuticals, Inc. Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases
US20080234213A1 (en) * 2005-09-02 2008-09-25 Matthias Wabl Oncogenic regulatory RNAs for diagnostics and therapeutics
US7459280B2 (en) * 2006-02-27 2008-12-02 Picobella, Llc Methods for diagnosing and treating kidney cancer
US20080267977A1 (en) * 2007-04-26 2008-10-30 Friedrich-Alexander University Of Erlangen-Nuremberg Combined immunological agent and sensitizing agent for the treatment of cancer
AU2013257710B2 (en) * 2012-05-08 2016-10-20 Cellixbio Private Limited Compositions and methods for the treatment of neurological disorders

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2442M (fr) 1962-10-17 1964-04-06 Henry Eugene L'acide dipropylacétique et ses dérivés en tant que nouveuax médicaments dépresseurs du systeme nerveux central.
US3701729A (en) 1970-06-01 1972-10-31 Tenneco Chem Oil-soluble mixed copper soap products
US3847956A (en) 1973-04-06 1974-11-12 Us Agriculture 2-hydroperoxycarboxylic acids and their preparation
US3932285A (en) 1973-10-03 1976-01-13 Tenneco Chemicals, Inc. Chromium salt compositions and a process for their production
US4025649A (en) 1974-08-19 1977-05-24 Labaz Acetic acid derivatives having pharmacological activity and compositions containing the same
US4129599A (en) 1975-04-28 1978-12-12 The Board Of Trustees Of Leland Stanford Jr. University A-Norsteroids
JPS5680116A (en) 1979-12-05 1981-07-01 Sanyo Electric Co Ltd Manufacture of substrate for magnetic bubble
JPH0233704B2 (ja) 1982-10-07 1990-07-30 Takeda Chemical Industries Ltd Chikanbinirukarubonsanjudotai
FR2599737B1 (fr) 1986-06-10 1989-05-19 Sanofi Sa Procede pour la fixation de groupes alkyles, alkenyles, cycloalkyles ou aralkyles sur une chaine carbonee portant un groupement fonctionnel
JPH01135740A (ja) 1987-11-24 1989-05-29 Nippon Mining Co Ltd 光学活性を有する２―アルキル―１―アルカン酸の製造方法
US5021398A (en) 1989-10-26 1991-06-04 Amp Incorporated Method of forming patterned oxide superconducting films
US5102913A (en) * 1991-07-01 1992-04-07 Halikas James A Treatment for cocaine use employing valproic acid
DE4231085A1 (de) * 1992-09-12 1994-03-17 Desitin Arzneimittel Gmbh VPA-analoge Antiepileptika
EP0661993B1 (en) 1992-09-16 1997-05-07 Genentech, Inc. Protection against liver damage by hgf
EP0670885B1 (en) 1992-11-30 1997-08-20 The Procter & Gamble Company High sudsing detergent compositions with specially selected soaps
JP3304459B2 (ja) 1992-12-18 2002-07-22 松下電器産業株式会社 電解コンデンサ駆動用電解液およびそれを用いた電解コンデンサ
EP0632008B1 (en) 1993-06-01 1998-02-04 Ono Pharmaceutical Co., Ltd. Pentanoic acid derivatives
US5503830A (en) 1993-09-10 1996-04-02 Petrovax, L.L.C. Compounds having immunostimulating activity and methods of use thereof
WO1995033044A1 (en) 1994-05-27 1995-12-07 The Procter & Gamble Company Liquid laundry detergent compositions comprising specially selected soaps
US5681854A (en) 1995-11-22 1997-10-28 Alcon Laboratories, Inc. Use of aliphatic carboxylic acid derivatives in ophthalmic disorders
IT1283489B1 (it) 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico

Also Published As

Publication number Publication date
KR20010071572A (ko) 2001-07-28
CZ20004833A3 (cs) 2002-01-16
EP1089725A1 (en) 2001-04-11
NO20006506L (no) 2001-02-21
PL345364A1 (en) 2001-12-17
AU752192B2 (en) 2002-09-12
CN1310622A (zh) 2001-08-29
AU4707199A (en) 2000-01-10
MXPA00012808A (es) 2002-04-24
HUP0102456A2 (hu) 2001-10-28
CA2335641A1 (en) 1999-12-29
BR9911421A (pt) 2001-03-27
SK19992000A3 (sk) 2001-08-06
IL140415A0 (en) 2002-02-10
US6268396B1 (en) 2001-07-31
ZA200007652B (en) 2002-03-19
TR200103249T2 (tr) 2002-05-21
TR200003800T2 (tr) 2001-06-21
HUP0102456A3 (en) 2003-07-28
BG105163A (en) 2002-03-29
WO1999066920A1 (en) 1999-12-29
JP2002518442A (ja) 2002-06-25
BG63744B1 (bg) 2002-11-29
AU5207199A (en) 2000-01-24
US6458840B2 (en) 2002-10-01
US20010031789A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE246500T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
HU9602583D0 (en) Gel for treatment of skin diseases and for disinfection of the skin
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
NO20014046D0 (no) Gabapentinderivater for forhindring og behandling av visceral smerte
DE69509544D1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
DE69627467D1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
NO20006506D0 (no) Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer
NO990433D0 (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
DE69526390D1 (de) Kugelförmige Aktivkohle zur Behandlung von Stoma-peripherer Entzündung
NZ333232A (en) Use of p-aminophenol derivatives (paracetamol) to treat neurodegenerative disease
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
IL143594A0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
NO20030295D0 (no) Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
HUP0104963A3 (en) Compositions for the treatment of skin diseases
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69519602D1 (de) Kugelförmige Aktivkohle zur Behandlung von Hämorrhoiden
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
GB9922710D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
DE69720410D1 (de) Therapeutisches Mittel zur Behandlung hartnäckiger Hundedermatitis
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application